Similar articles for PMID: 19912369

Year	Number of Results
1981	1
1999	1
2001	1
2002	1
2003	4
2004	2
2005	2
2006	6
2007	4
2008	3
2009	6
2010	4
2011	7
2012	8
2013	14
2014	11
2015	11
2016	14
2017	7
2018	1
2019	1
2020	5
2021	3
2022	2
2024	0

1

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Jarboe EA, et al. Histopathology. 2009 Nov;55(5):619. doi: 10.1111/j.1365-2559.2009.03408.x. Histopathology. 2009. PMID: 19912369 No abstract available.

2

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

Piek JM, Verheijen RH, van Diest PJ. Piek JM, et al. Histopathology. 2009 Mar;54(4):494-5. doi: 10.1111/j.1365-2559.2009.03237.x. Histopathology. 2009. PMID: 19309405 No abstract available.

3

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

Piek JM, Torrenga B, Hermsen B, Verheijen RH, Zweemer RP, Gille JJ, Kenemans P, van Diest PJ, Menko FH. Piek JM, et al. Fam Cancer. 2003;2(2):73-8. doi: 10.1023/a:1025700807451. Fam Cancer. 2003. PMID: 14574155

4

Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.

Staff S, Tolonen T, Laasanen SL, Mecklin JP, Isola J, Mäenpää J. Staff S, et al. Int J Gynecol Pathol. 2014 May;33(3):309-16. doi: 10.1097/PGP.0b013e31829c673b. Int J Gynecol Pathol. 2014. PMID: 24681744

5

The role of the fallopian tube in the origin of ovarian cancer.

Erickson BK, Conner MG, Landen CN Jr. Erickson BK, et al. Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10. Am J Obstet Gynecol. 2013. PMID: 23583217 Free PMC article. Review.

6

Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria.

Semmel DR, Folkins AK, Hirsch MS, Nucci MR, Crum CP. Semmel DR, et al. Mod Pathol. 2009 Aug;22(8):985-8. doi: 10.1038/modpathol.2009.64. Epub 2009 May 1. Mod Pathol. 2009. PMID: 19407856 Free PMC article.

7

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Crum CP, et al. Clin Med Res. 2007 Mar;5(1):35-44. doi: 10.3121/cmr.2007.702. Clin Med Res. 2007. PMID: 17456833 Free PMC article. Review.

8

BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis.

Piek JM, Verheijen RH, Kenemans P, Massuger LF, Bulten H, van Diest PJ. Piek JM, et al. Gynecol Oncol. 2003 Aug;90(2):491. doi: 10.1016/s0090-8258(03)00365-2. Gynecol Oncol. 2003. PMID: 12893227 No abstract available.

9

Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.

Press JZ, Wurz K, Norquist BM, Lee MK, Pennil C, Garcia R, Welcsh P, Goff BA, Swisher EM. Press JZ, et al. Neoplasia. 2010 Dec;12(12):993-1002. doi: 10.1593/neo.101044. Neoplasia. 2010. PMID: 21170264 Free PMC article.

10

Possible origin of ovarian cancer in the fallopian tubes.

Venkatesan P. Venkatesan P. Lancet Oncol. 2017 Dec;18(12):e714. doi: 10.1016/S1470-2045(17)30834-3. Epub 2017 Nov 2. Lancet Oncol. 2017. PMID: 29103868 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year